Related Experiment Video
Updated: Nov 24, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for
S Elissa Altin1, Yulanka S Castro-Dominguez2, Kevin F Kennedy3
1Division of Cardiology, Yale University, New Haven, Connecticut, USA; West Haven VA Medical Center, West Haven, Connecticut, USA.
Insights
Less than half of patients receive guideline-directed medical therapy (GDMT) after lower extremity (LE) peripheral vascular intervention (PVI). Women and high-risk patients were less likely to receive GDMT, highlighting a need for improved prescription practices.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Health Outcomes Research
Background:
- Guideline-directed medical therapy (GDMT) is crucial for managing patients with peripheral artery disease (PAD).
- Contemporary prescription rates of GDMT following lower extremity (LE) endovascular peripheral vascular intervention (PVI) are not well-established.
- Understanding factors influencing GDMT prescription is vital for optimizing patient care.
Purpose of the Study:
- To investigate the discharge prescription rates of GDMT after LE PVI.
- To identify predictors of GDMT prescription in patients undergoing LE PVI for symptomatic PAD.
Main Methods:
- Analysis of data from the 2014-2018 Vascular Study Group of New England Vascular Quality Initiative.
- Inclusion of 12,316 patients undergoing LE PVI for symptomatic PAD.
- Multivariate logistic regression to identify independent predictors of discharge GDMT prescription.
Main Results:
- Only 47.4% of patients were discharged on GDMT (antiplatelet agent, statin, ACE inhibitor/ARB).
- Antiplatelet agents were most common (95.2%), followed by statins (83.5%) and ACE inhibitors/ARBs (55.8%).
- Female sex, older age, end-stage renal disease, chronic limb-threatening ischemia, and congestive heart failure were negative predictors; hypertension, diabetes, CAD, and prior interventions were positive predictors.
Conclusions:
- Fewer than half of patients undergoing LE PVI receive appropriate GDMT.
- While traditional risk factors predict GDMT use, women and high-risk patients are less likely to receive it.
- Educational interventions are needed to address treatment gaps and improve GDMT prescription rates.
Objectives:
The aim of this study was to explore discharge prescription rates of guideline-directed medical therapy (GDMT), defined as aggregate antiplatelet agent, statin, and ACE inhibitor or angiotensin receptor blocker use after endovascular lower extremity (LE) peripheral vascular intervention.
Background:
Little is known about contemporary GDMT prescription following LE PVI.
Methods:
Sex, age, and comorbid conditions were related to discharge GDMT prescription among patients undergoing LE PVI for symptomatic peripheral artery disease in the 2014-2018 Vascular Study Group of New England Vascular Quality Initiative. Multivariate logistic regression was used to identify independent predictors of discharge GDMT prescription.
Results:
Among 12,316 patients, only 47.4% (n = 5,844) were discharged on GDMT after LE PVI. Most patients were discharged on antiplatelet agents (95.2%), with statins (83.5%) and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (55.8%) prescribed less often. A higher proportion of patients were on Class 1 guideline-recommended therapy with antiplatelet agents and statins (80.5%). In multivariate analysis, female sex, older age, end-stage renal disease, chronic limb-threatening ischemia, and congestive heart failure were negative predictors of discharge GDMT prescription, while hypertension, diabetes, coronary artery disease, and prior LE PVI or bypass were positive predictors.
Conclusions:
Fewer than one-half of patients undergoing LE PVI are discharged on appropriate GDMT. As expected, traditional atherosclerotic risk factors and measures of greater atherosclerotic disease burden were associated with a greater likelihood of GDMT prescription. However, women and patients with the highest risk for atherothrombosis and limb loss were least likely to be prescribed these agents. Provider- and patient-directed educational efforts are needed to close these treatment gaps.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
07:46Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction
Atherosclerosis III: Management